A Trial of HRS-1893 in Healthy Volunteers

A Phase II Clinical Trial of HRS-1893 in the Treatment of Heart Failure With Preserved Ejection Fraction

NCT07269717 ·Status: RECRUITING ·Phase: PHASE2

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of APL180

NCT00907998 ·Status: COMPLETED ·Phase: PHASE1

Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461

NCT02329184 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy

NCT04083339 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Safety and Efficacy of APL180 in Healthy Volunteers and Patients With Coronary Heart Disease (CHD)

NCT00568594 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study on the Efficacy and Safety of HRS-7535 in Patients With Mild Decrease in Ejection Fraction/Preserved Ejection Fraction Heart Failure and Obesity

NCT06820099 ·Status: RECRUITING ·Phase: PHASE2

A Study of HRS-5632 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events

NCT07185776 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy

NCT06979362 ·Status: RECRUITING ·Phase: PHASE2

A Single Ascending Dose Study Assessing the Safety, Tolerability, PK and PD of MYK-491

NCT03062956 ·Status: COMPLETED ·Phase: PHASE1

A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Reduced/Mildly Reduced Ejection Fraction and Left Ventricular Hypertrophy

NCT06979375 ·Status: RECRUITING ·Phase: PHASE2

Study to Assess Efficacy and Safety of CDR132L in Patients With Reduced Left Ventricular Ejection Fraction After Myocardial Infarction

NCT05350969 ·Status: COMPLETED ·Phase: PHASE2

A Thorough QT Study of Aticaprant (JNJ-67953964) in Healthy Adult Participants

NCT05387759 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics of Oral CK-1827452 in Patients With Stable Heart Failure

NCT00941681 ·Status: COMPLETED ·Phase: PHASE2

Beta 3 Agonist Treatment in Heart Failure

NCT01876433 ·Status: COMPLETED ·Phase: PHASE2

Safety and Tolerability Study of AZD4831 in Patients With Heart Failure.

NCT03756285 ·Status: TERMINATED ·Phase: PHASE2

Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic nHCM

NCT06081894 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Research Study on the Effects of NNC0537-1482 in Participants With Heart Failure

NCT07218627 ·Status: RECRUITING ·Phase: PHASE1

Forxiga HF General Drug Use-Results Study

NCT04865406 ·Status: COMPLETED

Reverse Remodeling Effects of CDR132L in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction and Cardiac Hypertrophy

NCT05953831 ·Status: WITHDRAWN ·Phase: PHASE2

A Study to Assess the Effect of Single Doses of Daridorexant on Electrocardiogram Parameters in Healthy Subjects

NCT04250506 ·Status: COMPLETED ·Phase: PHASE1

Study of JK07 in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF)

NCT04210375 ·Status: COMPLETED ·Phase: PHASE1

Efficacy, Safety, and Tolerability of Perhexiline in Subjects With Hypertrophic Cardiomyopathy and Heart Failure

NCT02431221 ·Status: WITHDRAWN ·Phase: PHASE3

A Safety, Tolerability, Pharmacokinetic Study of SHR-6934 Injection in Healthy Subjects

NCT06700083 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Study to Evaluate the Safety, Tolerability, and Efficacy of IMB-1018972 in Patients With Non-obstructive Hypertrophic Cardiomyopathy Trial

NCT04826185 ·Status: COMPLETED ·Phase: PHASE2

A Trial of SHR-4658 in Healthy Volunteers or Volunteers With Elevated Blood Pressure

NCT07230145 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1